ArticleAnnals of hematology2022

Single-agent 5-azacytidine as post-transplant maintenance in high-risk myeloid malignancies undergoing allogeneic hematopoietic cell transplantation.

Kevin-James Wattebled et al.PubMed ↗Publisher ↗

No numbers read from the abstract.